Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma

BACKGROUND: Hepatic artery infusion chemotherapy (HAIC) and anti-programmed cell death protein-1 (PD-1) immunotherapy have shown promising outcomes in patients with advanced hepatocellular carcinoma (HCC), respectively. However, the combination of the two treatments has not been reported. In this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Jie, Li, Shao-Hua, Li, Qi-Jiong, Sun, Xu-Qi, Lu, Liang-He, Lin, Wen-Ping, Zheng, Lie, Chen, Min-Shan, Shi, Ming, Wei, Wei, Guo, Rong-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007560/
https://www.ncbi.nlm.nih.gov/pubmed/33791252
http://dx.doi.org/10.2147/JHC.S298538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007560/
https://www.ncbi.nlm.nih.gov/pubmed/33791252
http://dx.doi.org/10.2147/JHC.S298538

Ejemplares similares